Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

Eligibility Criteria

• * Parent of a child who is diagnosed and being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
• * Parent has primary medication responsibility.
• * Pediatric patient aged 3-9 years
• * Child on therapy that includes home-based oral anti-cancer medication taken at home, such as 6-MP.
• * Parent has verbal English or Spanish fluency.
• * Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
• * Parent of a child who is not diagnosed nor being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
• * Parent does not have primary medication responsibility.
• * Pediatric patient aged 3-9 years
• * Pediatric patient is not on therapy that includes oral anti-cancer medication (e.g., 6-MP).
• * Parent does not have verbal English or Spanish fluency.
• * Parent is unwilling or unable to follow protocol requirements